PTAFR and neoplasm: Of note, inhibition of COX-2, a downstream cascade of PAFR signaling, via systemic administration of pharmacological COX-2 inhibitors, enhanced the anti-tumor efficacy of chemotherapy by blocking Tregs-mediated immunosuppression [153].